Advent International Bets $1B+ on Premium Body Care with Salt & Stone

Advent International has acquired Salt & Stone, the California-based premium body care brand, in a deal that values the six-year-old company north of $1 billion, according to sources familiar with the transaction. The acquisition marks one of the largest private equity bets on the direct-to-consumer personal care sector since the pandemic reshaped how Americans shop for deodorant, sunscreen, and skincare.

The deal, announced Monday, hands Advent control of a brand that's turned natural ingredients and coastal aesthetics into a cult following among wellness-conscious consumers — the kind who'll pay $28 for a single stick of deodorant if it promises aluminum-free pits and a scent profile described as "bergamot and hinoki." Salt & Stone has built that following largely online, through its own site and wholesale partnerships with retailers like Nordstrom and Sephora, positioning itself at the intersection of clean beauty and premium men's grooming.

For Advent, it's a straightforward play on a consumer shift that's proven durable even as economic uncertainty has pummeled other discretionary categories. The global natural and organic personal care market hit $15.6 billion in 2025 and is projected to grow at 9.3% annually through 2030, according to Grand View Research. Deodorant, once a commodity aisle afterthought, has become a statement purchase — and Salt & Stone has managed to command premium pricing while scaling distribution.

"We've been tracking the premiumization of personal care for several years, and Salt & Stone stood out not just for product quality but for how they've built a brand that resonates across gender lines and retail channels," said Sarah Chen, a partner at Advent who will join Salt & Stone's board. The firm declined to disclose purchase price or revenue multiples, but consumer goods deals in this segment have recently traded at 12-15x EBITDA when brands demonstrate strong repeat purchase rates and omnichannel traction.

Salt & Stone launched in 2020, founded by Nima Jalali, a former product designer who'd spent a decade at Nike and Patagonia. Jalali started with a single product — a natural deodorant formula that actually worked, a problem the clean beauty industry had notoriously struggled to solve — and expanded into sunscreen, lip balm, body wash, and skincare over the next three years.

The brand's growth came during a period when DTC brands were supposed to be dying. Venture-backed upstarts like Casper, Allbirds, and Warby Parker had proven that customer acquisition costs eventually eat young companies alive. But Salt & Stone sidestepped that trap by building wholesale partnerships early, landing in Nordstrom within 18 months and Sephora by year three. By 2024, roughly 60% of revenue came from retail, with the company's own e-commerce site handling the rest.

That hybrid model is what caught Advent's attention. Pure DTC plays are hard to scale profitably; pure wholesale plays sacrifice margin and brand control. Salt & Stone managed to do both, maintaining higher price points than mass-market competitors while still moving volume through physical retail. The company's hero product, its seaweed and sage deodorant, retails for $18-28 depending on size — roughly 3x the price of Old Spice or Dove.

The brand also benefited from cultural timing. Men's grooming, long an underdeveloped category, exploded during the pandemic as Zoom culture and self-care became normalized across demographics. Salt & Stone's minimalist packaging and gender-neutral branding let it straddle the men's and women's aisles without alienating either. Products are marketed as "natural" and "reef-safe" but avoid the preachy wellness-speak that can alienate mainstream buyers.

Advent's move reflects a broader private equity thesis: that consumers who've upgraded to premium personal care aren't downgrading, even in a recession. The firm has a history of buying challenger brands in consumer categories and scaling them through operational support and M&A. Recent consumer deals include the acquisition of Beautycounter (clean cosmetics) and a majority stake in Thorne HealthTech (supplements).

Salt & Stone fits that pattern — a brand with proven product-market fit that needs capital and infrastructure to reach the next stage of growth. Jalali will remain CEO and retain a minority stake, according to the announcement. The leadership team stays intact, a structure Advent has used before to keep founder vision alive while layering in corporate discipline.

The deal also arrives at a moment when legacy personal care giants are struggling to respond to indie challengers. Procter & Gamble, Unilever, and Colgate-Palmolive have all launched or acquired natural deodorant lines in recent years, but none have matched the brand heat of upstarts like Native (acquired by P&G for $100 million in 2017), Schmidt's (acquired by Unilever for an undisclosed sum in 2017), or Lume (reportedly valued at over $500 million in 2024).

What separates Salt & Stone from those earlier exits is its refusal to stop at deodorant. The company now has 40+ SKUs across seven product categories, giving it more pricing power and shelf space than single-product competitors. That breadth also makes it stickier with retailers, who prefer brands that can own a fixture rather than a single faceshelf.

The valuation multiple suggests Advent is pricing in aggressive international expansion. Salt & Stone currently generates about 85% of revenue in North America, leaving Europe, Asia, and Latin America largely untapped. The brand has distribution in select UK and Australian retailers but hasn't launched localized e-commerce or marketing in those regions.

One underappreciated element of the deal is Salt & Stone's sunscreen line, which launched in 2022 and now represents roughly 30% of revenue during peak summer months. The company's SPF 50 mineral sunscreen sells for $32 per bottle and has become a sleeper hit among surfers, trail runners, and parents willing to pay up for reef-safe formulas that don't leave a white cast. That's a harder product to formulate than deodorant — and a bigger competitive moat.

Deals like this aren't just about buying cash flow. They're about acquiring operating playbooks that can be replicated across portfolio companies. Advent now has a case study in how to build a premium consumer brand in 2025: go DTC first to prove product-market fit and control messaging, then layer in wholesale once you've built demand. Price high, design beautifully, market to both genders, and expand vertically within a lifestyle category rather than horizontally across unrelated products.

That playbook could get exported to other Advent consumer holdings or inform future acquisitions. The firm has long been a buyer of founder-led brands in categories where incumbents have gone stale. Personal care is one. Athletic apparel is another. Pet food, supplements, and home goods are all adjacent categories where similar dynamics are playing out.

The deal also gives Advent access to Salt & Stone's customer data — a trove of purchase behavior, repeat rates, and demographic insights that's worth more than the products themselves. DTC brands know what their customers buy, when they buy it, and how much they're willing to pay in ways that wholesale-dependent brands never could. That data can inform product development, pricing strategy, and marketing spend with precision that legacy CPG companies envy.

And there's a defensive element, too. As more private equity firms pile into consumer, the best assets are getting picked off quickly. Advent likely competed against several other bidders for Salt & Stone, and paying a premium now beats losing the deal and watching a competitor scale the brand for five years before flipping it at an even higher multiple.

The obvious risk is that private equity ownership kills the founder-led vibe that made Salt & Stone appealing in the first place. Indie beauty customers are sensitive to "selling out," and brands that get too polished or too corporate often lose the authenticity that built their following. Jalali staying on as CEO helps, but Advent will need to resist the temptation to strip out costs, homogenize the product line, or push for growth at the expense of brand integrity.

There's also the question of whether premium personal care can keep growing at these rates. The category has benefited from a decade-long wellness boom, but that trend isn't immune to economic downturns. If consumers start trading down to mass-market alternatives, Salt & Stone's pricing will become a vulnerability rather than a moat. The brand has no mid-tier or value offerings, which means it's all-in on the assumption that wellness spending is recession-proof.

Step back, and this deal is part of a larger story about how consumer goods is being restructured. For 50 years, personal care meant buying whatever P&G, Unilever, or Johnson & Johnson put on the shelf at Walmart. Brands like Old Spice, Dove, and Neutrogena dominated through distribution scale, not product innovation or emotional connection.

That model is breaking. Consumers — especially younger ones — increasingly want brands that reflect their values, whether that's sustainability, transparency, or just better design. They're willing to pay more for products that feel intentional rather than mass-produced. And they're comfortable discovering those brands online or in specialty retail rather than waiting for them to appear at Target.

Salt & Stone is one of dozens of brands chipping away at the legacy players' market share. Individually, none of them will replace P&G. Collectively, they're forcing the entire industry to rethink what premium means and who controls the relationship with the customer. Private equity is betting that this fragmentation is permanent — and that the brands winning today will be the category leaders in 20 years.

Whether that bet pays off depends on execution. Advent has five to seven years to scale Salt & Stone, expand internationally, and either take it public or sell to a strategic buyer. The firm will pour capital into product development, retail expansion, and digital marketing. The brand will get bigger, faster, and more professional. The question is whether it can do that without losing what made it worth $1 billion in the first place.

Expect Advent to push hard on international growth. Europe is the obvious next move — the region has high personal care spending, strong demand for natural products, and retail infrastructure that mirrors the U.S. Salt & Stone already has a presence in the UK through SpaceNK and Selfridges, giving it proof of concept. Rolling out across France, Germany, and Scandinavia is a logical 18-month priority.

Asia is trickier. Preferences around scent, texture, and formulation vary widely by country, and the brand would need to adapt products for local tastes. But the market size is too big to ignore — South Korea and Japan alone represent billions in premium beauty and personal care spending annually. Expect Advent to test selectively in key cities before committing to a full regional rollout.

Retailers like Sephora and Nordstrom will be watching closely to see if private equity ownership changes the brand's approach to wholesale. Salt & Stone has been a disciplined partner so far — it hasn't flooded the market with discounts or opened distribution too wide too fast. That restraint has kept the brand feeling premium even as it scaled.

But PE firms are under pressure to hit growth targets, and wholesale is the fastest way to juice revenue. If Advent pushes Salt & Stone into mid-tier retailers or starts offering promotions to hit quarterly numbers, it risks cheapening the brand. Retailers know this playbook — they've seen it before with other PE-backed beauty and personal care brands — and they'll be quick to pull back support if the brand loses its halo.

The flip side is that Advent's resources could make Salt & Stone a more attractive partner. The firm can fund exclusive product launches, in-store fixtures, and co-marketing campaigns that smaller indie brands can't afford. Done right, that could deepen relationships with key accounts and give Salt & Stone more leverage in shelf negotiations.

These figures are estimates based on typical category performance and retailer mix, but they illustrate why wholesale matters for a brand like Salt & Stone. DTC alone won't get you to $500 million in revenue. You need physical retail to hit scale — but you can't let retail dictate your brand identity.

Advent's job is to thread that needle. The firm has done it before with other consumer brands, but personal care is uniquely sensitive to over-distribution. The margin for error is narrow.

If you're running a DTC brand doing $10-50 million in revenue and wondering whether private equity is in your future, the Salt & Stone deal offers a blueprint. PE firms are hunting for brands that have proven product-market fit, demonstrated omnichannel traction, and built repeat purchase businesses in categories with durable consumer demand.

What they're not looking for: brands that only work online, single-product wonders with no expansion roadmap, or businesses that rely on paid social arbitrage to stay profitable. The 2015-2020 playbook of blitzscaling DTC brands with venture capital and hoping Facebook ads stay cheap is dead. The new playbook is slower, more deliberate, and far more focused on unit economics and wholesale relationships.

Salt & Stone checked every box. It started DTC to prove the product, expanded into wholesale to scale distribution, maintained premium pricing throughout, and built a multi-product portfolio that gives it staying power. That's the model that gets you to a $1 billion exit in 2026.

The other lesson: don't wait too long. Jalali sold after six years and roughly $100-150 million in estimated revenue (the company hasn't disclosed financials, but those figures align with comparable deals). That's earlier than many founders would prefer, but it's also before competition intensified, before a potential recession, and before Advent moved on to the next deal. Timing matters.

For other personal care and wellness brands watching this deal, the message is clear: if you've built something that works, the buyers are circling. PE firms have dry powder to deploy, consumer goods is in their crosshairs, and brands like Salt & Stone are proof that premium, founder-led companies can command serious multiples even in a cautious M&A environment.

Here's the thing that's easy to miss in all the deal metrics and growth projections: does the world actually need another private equity-backed personal care brand? Salt & Stone built something real — a product line people genuinely prefer and a brand identity that resonates beyond marketing copy. But once Advent plugs it into the same playbook it's used for a dozen other consumer acquisitions, does it stay distinctive, or does it become another well-capitalized challenger brand that eventually gets absorbed by Unilever or Estée Lauder?

That's the tension at the heart of these deals. Private equity can provide the capital and infrastructure to scale, but scale has a way of sanding down the edges that made a brand interesting in the first place. The next five years will show whether Advent can grow Salt & Stone without homogenizing it.

And if the brand does lose its way? There are a hundred other indie personal care startups waiting to fill the void, each with a slightly different take on natural ingredients and minimalist branding. The cycle continues.

For now, though, Advent has its bet. A billion dollars says that the consumer who upgraded from Degree to Salt & Stone isn't switching back — even if the label no longer says "founder-owned." Whether that's true is the only question that matters.